Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yi Hui Biotechnology, commonly known as Yi Hui Biotech or E-Hui Biotech, is a specialized contract research organization (CRO) based in Shanghai, China. Founded in 2015, the company focuses on providing high-throughput screening (HTS) and automated compound library management services to the global pharmaceutical and biotechnology industries. Yi Hui Biotech operates a state-of-the-art platform that integrates robotics and advanced informatics to facilitate large-scale biological assays and chemical storage. Their expertise includes assay development, lead identification, and the management of diverse chemical collections for drug discovery programs. The company plays a significant role in supporting the early-stage R&D infrastructure within the Zhangjiang Hi-Tech Park. By offering scalable and efficient screening solutions, Yi Hui Biotech helps partners accelerate the transition from target identification to lead optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 易慧生物技术.